α-Actinin-4 promotes the progression of castration-resistant prostate cancer.

被引：0
|
作者：
Park, S. [1 ]
Ko, J. [1 ]
机构：
[1] Korea Univ, Life Sci, Seoul, South Korea
来源：
MOLECULAR BIOLOGY OF THE CELL | 2018年 / 29卷 / 26期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P2100
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Characterization of PSA at death in patients with metastatic castration-resistant prostate cancer.
    Bikkasani, Krishna
    Qin, Qian
    Lin, Justin
    Galsky, Matt D.
    Liaw, Bobby Chi-Hung
    Oh, William K.
    Tsao, Che-Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [42] Identifying enzalutamide resistance mechanisms in men with castration-resistant prostate cancer.
    Alumkal, Joshi J.
    Heiser, Laura
    Beer, Tomasz M.
    Small, Eric Jay
    Baertsch, Robert
    Stuart, Josh
    King, Carly
    Korkola, James
    Cetnar, Jeremy
    Graff, Julie Nicole
    Thomas, George
    Ryan, Christopher W.
    Toschi, Alexandria
    Youngren, Jack
    Tucker, Erin
    Ellers, Kristi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] N-cadherin promotes castration-resistant prostate cancer progression by enhancing stem cell properties of prostate cancer cells
    Lin, Shu
    Stonyanova, Tanya
    Kono, Evelyn
    Matsuura, Jaclyn
    Kobayashi, Naoko
    Yamashiro, Joyce
    Hong, Dai
    Witte, Owen N.
    Goldstein, Andrew S.
    Reiter, Robert E.
    CANCER RESEARCH, 2016, 76
  • [44] ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer
    J R Gsponer
    M Braun
    V J Scheble
    T Zellweger
    A Bachmann
    S Perner
    T Vlajnic
    M Srivastava
    S-H Tan
    A Dobi
    I A Sesterhenn
    S Srivastava
    L Bubendorf
    C Ruiz
    Prostate Cancer and Prostatic Diseases, 2014, 17 : 126 - 131
  • [45] ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer
    Gsponer, J. R.
    Braun, M.
    Scheble, V. J.
    Zellweger, T.
    Bachmann, A.
    Perner, S.
    Vlajnic, T.
    Srivastava, M.
    Tan, S-H
    Dobi, A.
    Sesterhenn, I. A.
    Srivastava, S.
    Bubendorf, L.
    Ruiz, C.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (02) : 126 - 131
  • [46] Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer
    Ye, Chen
    Chen, Guang-Hua
    Chen, Xin
    Qin, Sheng-Fei
    Shi, Min-Feng
    Zhou, Tie
    ASIAN JOURNAL OF ANDROLOGY, 2020, 22 (04) : 422 - 426
  • [47] Darolutamide For Castration-Resistant Prostate Cancer
    Bastos, Diogo A.
    Antonarakis, Emmanuel S.
    ONCOTARGETS AND THERAPY, 2019, 12 : 8769 - 8777
  • [48] Immunotherapy for Castration-Resistant Prostate Cancer
    Sonpavde, Guru
    Kantoff, Philip W.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 465 - +
  • [49] Chemotherapy for castration-resistant prostate cancer
    Berthold, D.
    ONKOLOGIE, 2011, 34 : 12 - 12
  • [50] Strategies in castration-resistant prostate cancer
    Bessede, Th
    PROGRES EN UROLOGIE, 2011, 21 : S68 - S71
12345